Cellosaurus logo
expasy logo

Cellosaurus 92-13 (CVCL_C6NG)

[Text][XML][JSON]
Cell line name 92-13
Accession CVCL_C6NG
Resource Identification Initiative To cite this cell line use: 92-13 (RRID:CVCL_C6NG)
Comments Group: Patented cell line.
Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-10628.
Biotechnology: When radiolabeled with Yttrium-90 the monoclonal antibody produced by this hybridoma can be used for the treatment of synovial sarcomas.
Monoclonal antibody isotype: IgG2a.
Monoclonal antibody target: UniProtKB; Q9ULW2; Human FZD10.
Species of origin Mus musculus (Mouse) (NCBI Taxonomy: 10090)
Hierarchy Parent: CVCL_3412 (P3X63Ag8U.1)
Category Hybridoma
Publications

PubMed=18271942; DOI=10.1111/j.1349-7006.2007.00701.x; PMCID=PMC11159395
Chikako Fukukawa, Hirofumi Hanaoka, Satoshi Nagayama, Tatsuhiko Tsunoda, Junya Toguchida, Keigo Endo, Yusuke Nakamura, Toyomasa Katagiri;
Radioimmunotherapy of human synovial sarcoma using a monoclonal antibody against FZD10.
Cancer Sci. 99:432-440(2008)

Patent=US9139655
Yusuke Nakamura, Toyomasa Katagiri, Shuichi Nakatsuru, Keigo Endo;
Tumor-targeting monoclonal antibodies to FZD10 and uses thereof.
Patent number US9139655, 22-Sep-2015

Cross-references
Encyclopedic resources Wikidata; Q116048433
Entry history
Entry creation15-Dec-2022
Last entry update21-Mar-2023
Version number2